» Articles » PMID: 6213200

Comparative in Vitro Activity of Norfloxacin (MK-0366) and Ten Other Oral Antimicrobial Agents Against Urinary Bacterial Isolates

Overview
Specialty Pharmacology
Date 1982 May 1
PMID 6213200
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid, nitrofurantoin, co-trimoxazole, trimethoprim, sulfamethoxazole, cinoxacin, tetracycline, ampicillin, carbenicillin, and cephalexin against 628 urinary bacterial isolates. Norfloxacin was the most active antimicrobial agent tested against the gram-negative bacilli. It was less active than a few of the other antimicrobial agents against enterococci and Staphylococcus aureus.

Citing Articles

Inappropriate breast secretions of possible bacterial etiology in the parous nonpuerperal female.

Freeman J, ALTIERI R, Freeman A, Kuo T, Sardinha F, Buckingham C J Natl Med Assoc. 1994; 86(3):203-8.

PMID: 8189453 PMC: 2568182.


In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Eliopoulos G, Gardella A, Moellering Jr R Antimicrob Agents Chemother. 1984; 25(3):331-5.

PMID: 6721464 PMC: 185510. DOI: 10.1128/AAC.25.3.331.


In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.

Nakamura S, Minami A, Katae H, Inoue S, Yamagishi J, Takase Y Antimicrob Agents Chemother. 1983; 23(5):641-8.

PMID: 6575721 PMC: 184780. DOI: 10.1128/AAC.23.5.641.


In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.

Garcia I, Bodey G, Fainstein V, Ho D, LeBlanc B Antimicrob Agents Chemother. 1984; 26(3):421-3.

PMID: 6508271 PMC: 176185. DOI: 10.1128/AAC.26.3.421.


Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.

DARRELL R, Modak S, FOX Jr C Trans Am Ophthalmol Soc. 1984; 82:75-91.

PMID: 6242083 PMC: 1298655.


References
1.
Ito A, Hirai K, Inoue M, Koga H, SUZUE S, IRIKURA T . In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother. 1980; 17(2):103-8. PMC: 283741. DOI: 10.1128/AAC.17.2.103. View

2.
Hirai K, Ito A, Abe Y, SUZUE S, IRIKURA T, Inoue M . Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections. Antimicrob Agents Chemother. 1981; 19(1):188-9. PMC: 181380. DOI: 10.1128/AAC.19.1.188. View